90 related articles for article (PubMed ID: 27173147)
1. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: long-term results of a phase II study.
Tyc-Szczepaniak D; Wyrwicz L; Wiśniowska K; Michalski W; Pietrzak L; Bujko K
Acta Oncol; 2016 Nov; 55(11):1369-1370. PubMed ID: 27173147
[No Abstract] [Full Text] [Related]
2. Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastases.
Ayez N; Burger JW; van der Pool AE; Eggermont AM; Grunhagen DJ; de Wilt JH; Verhoef C
Dis Colon Rectum; 2013 Mar; 56(3):281-7. PubMed ID: 23392140
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study.
Tyc-Szczepaniak D; Wyrwicz L; Kepka L; Michalski W; Olszyna-Serementa M; Palucki J; Pietrzak L; Rutkowski A; Bujko K
Ann Oncol; 2013 Nov; 24(11):2829-34. PubMed ID: 24013512
[TBL] [Abstract][Full Text] [Related]
4. The adequacy of the distal resection margin after preoperative chemoradiotherapy for rectal cancer.
Kim TG; Park W; Choi DH; Kim SH; Kim HC; Lee WY; Park JO; Park YS
Colorectal Dis; 2014 Aug; 16(8):O257-63. PubMed ID: 24422744
[TBL] [Abstract][Full Text] [Related]
5. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.
Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S
Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247
[TBL] [Abstract][Full Text] [Related]
6. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
7. Analysis of bevacizumab-based preoperative radiochemotherapy in patients with locally advanced rectal cancer on surgery-associated spectrum of complications.
Dellas K; Buller J; Görtz GJ; Richter M; Höhler T; Arnold D; Keck T; Dunst J; Zühlke H
Ann Surg Oncol; 2014 Apr; 21(4):1352-60. PubMed ID: 24306667
[TBL] [Abstract][Full Text] [Related]
8. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.
Ruby JA; Leibold T; Akhurst TJ; Shia J; Saltz LB; Mazumdar M; Riedel ER; Larson SM; Guillem JG
Dis Colon Rectum; 2012 Apr; 55(4):378-86. PubMed ID: 22426260
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study.
Ding P; Liska D; Tang P; Shia J; Saltz L; Goodman K; Downey RJ; Nash GM; Temple LK; Paty PB; Guillem JG; Wong WD; Weiser MR
Ann Surg; 2012 Jul; 256(1):111-6. PubMed ID: 22664562
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older.
Margalit DN; Mamon HJ; Ancukiewicz M; Kobayashi W; Ryan DP; Blaszkowsky LS; Clark J; Willett CG; Hong TS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e735-41. PubMed ID: 21377289
[TBL] [Abstract][Full Text] [Related]
12. Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Eisterer W; De Vries A; Öfner D; Rabl H; Koplmüller R; Greil R; Tschmelitsch J; Schmid R; Kapp K; Lukas P; Sedlmayer F; Höfler G; Gnant M; Thaler J;
Anticancer Res; 2014 Nov; 34(11):6767-73. PubMed ID: 25368289
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
14. The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
Kao PS; Chang SC; Wang LW; Lee RC; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lin JK
J Surg Oncol; 2010 Dec; 102(7):771-7. PubMed ID: 20872811
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of postoperative adjuvant therapy in Stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: 10-year follow-up.
Kim TW; Lee JH; Lee JH; Ahn JH; Kang YK; Lee KH; Yu CS; Kim JH; Ahn SD; Kim WK; Kim JC; Lee JS
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1025-31. PubMed ID: 20932669
[TBL] [Abstract][Full Text] [Related]
16. Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: A comparison of the short- and long-term outcomes in patients with T3 rectal cancer.
Beppu N; Matsubara N; Noda M; Yamano T; Kakuno A; Doi H; Kamikonya N; Kimura F; Yamanaka N; Yanagi H; Tomita N
Surgery; 2015 Jul; 158(1):225-35. PubMed ID: 25900036
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R;
Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104
[TBL] [Abstract][Full Text] [Related]
19. Local excision following pre-operative chemoradiotherapy-induced downstaging for selected cT3 distal rectal cancer.
Yeo SG; Kim DY; Kim TH; Kim SY; Chang HJ; Park JW; Choi HS; Oh JH
Jpn J Clin Oncol; 2010 Aug; 40(8):754-60. PubMed ID: 20457724
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).
Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
